Cogent Biosciences, Inc. (COGT)
39.90
+0.96
(+2.47%)
USD |
NASDAQ |
Jan 20, 11:04
Cogent Biosciences EPS Diluted (Quarterly): -0.5884 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Cidara Therapeutics, Inc. | -3.096 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| ADMA Biologics, Inc. | 0.1489 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -80.93M |
| Total Expenses (Quarterly) | 80.93M |
| Enterprise Value | 5.755B |
| Earnings Yield | -5.94% |
| Normalized Earnings Yield | -5.941 |